Adagio Medical Holdings Inc (NASDAQ:ADGM) shares are trading higher by 124% to $2.07 during Thursday’s session after the FDA granted Breakthrough Device Designation for the vCLAS cryoablation system.
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback